Influvac Tetra

Medicinal product

(Invented) name

Influvac Tetra

Active substance (s)

A/Victoria/4897/2022 (H1N1)pdm09 panaši padermė (A/Victoria/4897/2022 IVR‐238)/A/Croatia/10136RV/2023 (H3N2) – panaši padermė (A/Croatia/10136RV/2023, X-425A)/B/Austria/1359417/2021 panaši padermė (B/Austria/1359417/2021, BVR-26)/Į B/Phuket/3073/2013 panaši padermė (B/Phuket/3073/2013, laukinis tipas)

Strength

15 µg HA/15 µg HA/15 µg HA/15 µg HA/dozėje

Pharmaceutical form

injekcinė suspensija užpildytame švirkšte

Route (s) of administration

leisti į raumenis, leisti po oda

Purpose for use

2025-2026 sezonas

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

ATC code (s)

J07BB02, influenza, inactivated, split virus or surface antigen

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2023-06-15

Date of renewal

Documents

1914_Influvac Tetra_2025-08-21_K.docx

Stage

Registruotas

Controlled?

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Užpildytame švirkšte (0,5 ml) yra	0.5 ml
A/Victoria/4897/2022 (H1N1)pdm09 panaši padermė (A/Victoria/4897/2022 IVR‐238)	15 µg HA
A/Croatia/10136RV/2023 (H3N2) – panaši padermė (A/Croatia/10136RV/2023, X-425A)	15 µg HA
B/Austria/1359417/2021 panaši padermė (B/Austria/1359417/2021, BVR-26)	15 µg HA
Į B/Phuket/3073/2013 panaši padermė (B/Phuket/3073/2013, laukinis tipas)	15 µg HA

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
111159	97270	1097270	užpildytas švirkštas	0,5 ml su adata N1		Receptinis	LT/L/23/1914/001	Netiekiama	2025-09-17	2026-03-30	No	-	-	Download

Stadijos

Data	Stadija
2023-06-15	Registruotas